Minnebio
Established in December 2018, MinneBio has evolved into a sustainable supplier in biotechnology, specializing in enzymes such as ultra-active nuclease (Benzonase), proteinase K, and cytokines like human interleukins-2, 6, 10, 12, 15, and cell culture media. Our products serve academic research, therapeutic trials, and pharmaceutical development, ensuring reliability and quality. Committed to customer satisfaction, we offer the best solutions with our advanced platform for peptides, proteins, and antibodies, tailored to meet specific customer requirements. At MinneBio, we prioritize customer needs by actively listening and delivering exceptional products and services.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
4
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Minnebio
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- TW
Tyler Wacker
Software Development Intern · Information Technology
EmailPhone - DL
David Liang
CEO of Minnebio Editor of Computational & Structural Biotechnology Journal · Other
EmailPhone
Showing 2 of 4 verified contacts
Top roles at Minnebio
4 distinct titles indexed · top 4 shown.
- 1ceo of minnebio editor of computational & structural biotechnology journal
- 1president
- 1software development intern
- 1technical aide
Sign up to unlock all 4 contacts at Minnebio
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Minnebio
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.